Act Now to Protect Drug Development. As part of the budgeting process, Congress is discussing cutting back the Orphan Drug Tax Credit for pharmaceutical companies. Most of the drugs in sarcoidosis are not FDA-approved for sarcoidosis, but are repurposed from...
I have sarcoidosis and am a Patient Advocate. In the Fall of 2020, I was diagnosed with neurosarcoidosis. The biggest question I struggled with after my diagnosis was, “What do I do now?”. My life was completely upended. I struggled with new treatments...
What to know about Omicron, the vaccines, the boosters, and staying safe The Omicron variant of the COVID-19 virus is now the dominant variant in the United States and since December cases have been skyrocketing. Vaccines and boosters What makes this variant...
This year, the Foundation for Sarcoidosis Research (FSR) has made incredible progress towards our mission thanks to your support! There have been significant strides made towards accelerating research initiatives and providing resources to patients around the...
